Julie Waras Brogren

Deputy CEO & Chief Commercial Officer

Professional background: Julie Waras Brogren (born 1972) has extensive experience from life science leadership roles in finance, global product launches and general management. She was previously President of BresoTEC, a Canada HealthTech and has held various leadership positions at Novo Nordisk in Latin America and in global teams, including as head of the Global Launch Office for the Victoza® GLP-1 and degludec insulin. Julie Waras Brogren also has experience as Board member of life science companies. Julie Waras Brogren started her career at Accenture.

Julie joined Ascelia Pharma in 2022.

Education: M.Sc. in International Business from Copenhagen Business School and Diplome ESC, EM Lyon France, including studies at Chinese University of Hong Kong.

Holdings in Ascelia: View holdings